Male pseudohermaphroditism caused by mutations of testicular 17β–hydroxysteroid dehydrogenase 3

Wayne M. Geissler(Merck & Co., Inc., Rahway, NJ, USA (United States)), Stefan Andersson(The University of Texas Southwestern Medical Center), David W. Russell(Pfizer (United States)), Sushma Patel(Merck & Co., Inc., Rahway, NJ, USA (United States)), Keith Elliston(ACT Foundation), Ling Wu(Merck & Co., Inc., Rahway, NJ, USA (United States)), Jean D. Wilson(The University of Texas Southwestern Medical Center), Berenice B. Mendonça(Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo), Daphne L. Davis(The University of Texas Southwestern Medical Center), Karen D. Bradshaw(The University of Texas Southwestern Medical Center)
Nature Genetics
May 1, 1994
Cited by 573


Related Papers